Post by Incyte

144,099 followers

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma in adults worldwide, and there is a high medical need for new, effective therapies. Learn more from Steven Stein, M.D., Executive Vice President, Chief Medical Officer and Head of Late-stage Development, as he discusses the significance of the data we shared for patients with previously untreated DLBCL at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting. https://bit.ly/4vc6uhc

Post content

Video Content